By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity
Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis
Just soft, warm, and easy
Weight loss medications have existed for a while, but they tended to be associated with limited weight loss results and problematic side effects, which did not allow for a wide-spread adoption by the masses
Once contracted, the herpes virus remains dormant in the body, leading to periodic flare-ups that can be distressing for those affected
Security policy Delivery policy Return policy BioTech USAs L-Carnitine 100.000 delivers 2000 mg of L-Carnitine per serving in highly dosed liquid form